• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

WHO Lists First Diagnostic Test for Zika Virus

Article

August 19, 2016

altona Diagnostics (Hamburg, Germany) reports that its Zika Virus RT-PCR Kit 1.0 has been listed by WHO as first in vitro diagnostic test eligible for procurement agencies and member states.   The kit was assessed under the Emergency Use Assessment and Listing Procedure (EUAL), an emergency assessment mechanism established by WHO during the 2014 Ebola Virus Disease outbreak.    A public report with additional details about the WHO EUAL listing for the testing kit for can be found at http://www.who.int/diagnostics_laboratory/eual-zika-virus/zika/en/   

Related Videos
Related Content
Say Hello to Flexible: Reimagining the Patient Journey

Say Hello to Flexible: Reimagining the Patient Journey

April 15th 2024
Article

Through embracing connected and tech-enabled services and devices, new avenues and opportunities exist for greater clinical trial flexibility in drug research.

Stock.adobe.com

ArisGlobal Announces Second Life Sciences Generative AI Council Session

April 11th 2024
Article

The meeting is scheduled for May in Switzerland.

Image credit: ArtemisDiana | stock.adobe.com

Precision Medicine: Investments and Outcomes Expected

March 18th 2024
Article

Precision medicine is now seen as a healthcare approach for both the present and the future, particularly with the explosion of personalized care delivery.

Dan Milczarski, Executive Vice President of Process and Technology, CQfluency.

All in on AI is Not the Solution in Life Sciences and Health Care

March 13th 2024
Article

Although life science organizations are not immune to the benefits of artificial intelligence, it’s important to integrate it with caution because there is no “one-size fits all” approach.

Andrew Anderson

Normalizing Data with AI: Q&A with Andrew Anderson, VP of Innovation and Informatics Strategy at ACD/Labs

March 8th 2024
Article

Anderson discusses how AI can be used to take data collected by different processes and bring it into a usable format.

Deborah L. Ancona, Seley Distinguished Professor of Management, Professor of Organization Studies, founder of the MIT Leadership Center at the MIT Sloan School of Management.

With Generative AI, Layoffs Increasing Complexity for C-Suites in 2024, What Playbook Should Executives Deploy for the Next Three Quarters?

February 27th 2024
Article

A Harvard Business School Healthcare Alumni Association (HBSHAA) Q&A with Professor Deborah Ancona, founder of the MIT Leadership Center.